MedTrace Logo

Phonak Behind-The-Ear Quality Evaluation

NCT05956808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-08-21

No results posted yet for this study

Summary

Subjective listening effort and objective speech intelligibility will be evaluated with a new generation of a Phonak BTE (Behind-The-Ear) hearing aid.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Phonak Naida BTE hearing aid

Newest generation of ultra-power Phonak BTE hearing aids

DEVICE

Phonak Naida legacy BTE hearing aid

Previous model/generation of the Naida BTE hearing aid

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2023-08-16
Completion
2023-08-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05956808 on ClinicalTrials.gov